Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19213635 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213628 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213629 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213632 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213644 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213645 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213638 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213643 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213636 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL19213633 | 0.97 | KDM4E (0.35) | KDM4EATML3MBTL1F2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10170707-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-01-01 | — | — | US | disclosed |
| US-20180145265-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-24 | — | — | US | disclosed |
| US-20180145265-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-24 | — | — | US | disclosed |
| US-20170229661-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170229661-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170229661-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | RER1, LEF1, L1CAM | KDM4E 2880/4885ATM 1590/4885L3MBTL1 223/4885 |
| US-20180145265-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | RER1, LEF1, L1CAM | KDM4E 2880/4885ATM 1590/4885L3MBTL1 223/4885 |
| US-10170707-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device | RER1, LEF1, L1CAM | KDM4E 2880/4885ATM 1590/4885L3MBTL1 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.